Late phase IIIb and IV clinical trials are crucial for gathering real-world evidence. uMotif’s unique eCOA/ePRO platform is flexible to meet the requirements all types of late phase clinical trials from virtual to site-based studies.

Uniquely designed with patients, for patients, our platform helps reduce the burden of study participation to drive high levels of patient participation and compliance, in every study.

Available in any language and swiftly configured for global deployment for late phase clinical trials, uMotif’s validated platform supports the delivery of large-scale late phase trials across the globe. We achieve high rates of data capture and participant compliance and retention that often far exceeds our customers’ expectations.